Retour aux projets

12638.1;12 PFLS-LS

TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS

Résumé

TOWARDS A NOVEL COMBINATION THERAPY AGAINST HUMAN TUMORS BASED ON THE SYNERGISTIC ANTI-CANCER EFFECT OF TWO NON-CANCER DRUGS

Textes supplémentaires

Abstract

It was recently discovered at the University of Basel that combining a well known metabolic drug with a drug not previously reported to have any potential for the treatment of cancer led to an unexpected and synergistic anti-tumor effect. We aim to pursue this novel anti-cancer approach to the clinic. Proposed are chemical modifications to optimize one of the combination partners, as well as toxicological and pharmacological studies. In parallel, mechanistic studies, including identification of drug binding/effector genes, will be performed in order to define biomarkers of drug response and guide drug development.

Participants

Michael Hall

Kontaktperson

m.hall@unibas.ch

Universität Basel Michael Hall Klingelbergstrasse 70 4056 Basel BS CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2011-09-30
Date de fin
2014-06-16
Coûts totaux approuvés
CHF 681440.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%